Three years have passed since the FDA announced that it had detected counterfeit versions
of the injectable anticancer drug bevacizumab (Avastin®, Genentech, USA) in the US drug …

Falsified medical products have become a global threat since they were first mentioned to
the general public at the conference of experts on the rational use of drugs organized by the …

Purpose A comparison of anti–vascular endothelial growth factor (anti-VEGF) medication
use across multiple countries. Clinical Relevance Anti-VEGF medication use is now …

Biopharmaceuticals have established themselves as highly efficient medicines, and are still
one of the fastest growing parts of the health-product industry. Unfortunately, the introduction …

Purpose To report the recent controversy surrounding the intraocular use of bevacizumab in
India and its relationship to the broader problems of off-label drug use, medication …

Purpose This study reports the findings in a large series of patients with acute bacterial
endophthalmitis after intravitreal injection of bevacizumab (IVB) in two eye hospitals …

Objective To explore healthcare policy and system improvements that would more
proactively respond to future penetration of counterfeit cancer medications in the USA drug …

Advances in biotechnology and the chemical synthesis of peptides have made
biopharmaceuticals and synthetic peptide drugs viable pharmaceutical compounds today …

Purpose To study features, management and outcomes of cluster endophthalmitis following
intravitreal bevacizumab (BCZ) injection in North India. Methods In this retrospective study …

Aim To report the clinical profile, outcomes of early vitrectomy for cluster endophthalmitis
developing after intravitreal Bevacizumab (IVB), and discuss the role of prophylactic …